{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:49:26Z","timestamp":1789494566776,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-023-03315-1","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T07:02:26Z","timestamp":1693983746000},"page":"872-879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy"],"prefix":"10.1007","volume":"26","author":[{"given":"\u00d3scar","family":"Mu\u00f1oz Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edas","family":"Gomis Sell\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blas David","family":"Delgado Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Mateos Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Baeza Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Perucha Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-3751","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"L\u00f3pez Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cabrera Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"issue":"9","key":"3315_CR1","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ejca.2013.09.002","volume":"51","author":"M Arnold","year":"2015","unstructured":"Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European cancer observatory. Eur J Cancer. 2015;51(9):1164\u201387. https:\/\/doi.org\/10.1016\/j.ejca.2013.09.002. (Epub 2013 Oct 8 PMID: 24120180).","journal-title":"Eur J Cancer"},{"issue":"6","key":"3315_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877\u201392.","journal-title":"Eur Urol Oncol"},{"issue":"8","key":"3315_CR3","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941\u201353.","journal-title":"Int J Cancer"},{"issue":"11b","key":"3315_CR4","doi-asserted-by":"publisher","first-page":"E701","DOI":"10.1111\/j.1464-410X.2012.11504.x","volume":"110","author":"JM C\u00f3zar","year":"2012","unstructured":"C\u00f3zar JM, Mi\u00f1ana B, G\u00f3mez-Veiga F, Rodr\u00edguez-Antol\u00edn A, Villavicencio H, on behalf of 25 Urology Units, Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda, et al. (2012) Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010: prostate cancer incidence and patient profile. BJU Int. 2012;110(11b):E701\u20136.","journal-title":"BJU Int"},{"issue":"2","key":"3315_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243\u201362.","journal-title":"Eur Urol"},{"issue":"6","key":"3315_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/iju.12373","volume":"21","author":"H Sasaki","year":"2014","unstructured":"Sasaki H, Kido M, Miki K, Kuruma H, Takahashi H, Aoki M, et al. Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy: salvage partial brachytherapy. Int J Urol. 2014;21(6):572\u20137.","journal-title":"Int J Urol"},{"key":"3315_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.radonc.2021.12.047","volume":"167","author":"A Henry","year":"2022","unstructured":"Henry A, Pieters BR, Andr\u00e9 Siebert F, Hoskin P. GEC-ESTRO ACROP prostate brachytherapy guidelines. Radiother Oncol. 2022;167:244\u201351.","journal-title":"Radiother Oncol"},{"issue":"2","key":"3315_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00345-012-0928-8","volume":"31","author":"M Peters","year":"2013","unstructured":"Peters M, Moman MR, van der Poel HG, Vergunst H, de Jong IJ, Vijverberg PLM, et al. Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review. World J Urol. 2013;31(2):403\u20139.","journal-title":"World J Urol"},{"issue":"3","key":"3315_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4111\/icu.2020.61.3.269","volume":"61","author":"J Suh","year":"2020","unstructured":"Suh J, Jung JH, Jeong CW, Lee SE, Lee E, Ku JH, et al. Long-term oncologic outcomes after radical prostatectomy in clinically localized prostate cancer: 10\u00a0year follow-up in Korea. Investig Clin Urol. 2020;61(3):269.","journal-title":"Investig Clin Urol"},{"key":"3315_CR10","unstructured":"Arenas Prat M, Ferrer Albiach C. (2021) Libro blanco de la oncolog\u00eda radioter\u00e1pica en Espa\u00f1a"},{"issue":"5","key":"3315_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bju.14838","volume":"124","author":"T Hostiou","year":"2019","unstructured":"Hostiou T, Gelet A, Chapelon JY, Rouvi\u00e8re O, M\u00e8ge-Lechevalier F, Lafon C, et al. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes. BJU Int. 2019;124(5):746\u201357. https:\/\/doi.org\/10.1111\/bju.14838. (Epub 2019 Jul 2 PMID: 31148367).","journal-title":"BJU Int"},{"issue":"1","key":"3315_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1748-717X-9-102","volume":"9","author":"I Henr\u00edquez","year":"2014","unstructured":"Henr\u00edquez I, Sancho G, Herv\u00e1s A, Guix B, Pera J, Gutierrez C, et al. Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiat Oncol. 2014;9(1):102.","journal-title":"Radiat Oncol"},{"issue":"3","key":"3315_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","volume":"80","author":"LF Valle","year":"2021","unstructured":"Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, et al. A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER). Eur Urol. 2021;80(3):280\u201392.","journal-title":"Eur Urol"},{"issue":"2","key":"3315_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/21681805.2014.968869","volume":"49","author":"K KvorningTernov","year":"2015","unstructured":"KvorningTernov K, KragJakobsen A, Bratt O, Ahlgren G. Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer. Scand J Urol. 2015;49(2):115\u20139. https:\/\/doi.org\/10.3109\/21681805.2014.968869. (Epub 2014 Nov 27 PMID: 25428754).","journal-title":"Scand J Urol"},{"issue":"6","key":"3315_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.brachy.2016.08.004","volume":"15","author":"MS Rutenberg","year":"2016","unstructured":"Rutenberg MS, Meister M, Amin PP, Hussain A, Naslund MJ, Kwok Y. Salvage external beam radiotherapy for locally recurrent prostate cancer after definitive brachytherapy. Brachytherapy. 2016;15(6):722\u20139.","journal-title":"Brachytherapy"},{"key":"3315_CR16","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3315_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, Van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243\u201362. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042. (Epub 2020 Nov 7 PMID: 33172724).","journal-title":"Eur Urol"},{"issue":"4","key":"3315_CR18","doi-asserted-by":"publisher","first-page":"e2021191","DOI":"10.23750\/abm.v92i3.11475","volume":"92","author":"U Maestroni","year":"2021","unstructured":"Maestroni U, Tafuri A, Dinale F, Campobasso D, Antonelli A, Ziglioli F. Oncologic outcome of salvage high-intensity focused ultrasound (HIFU) in radiorecurrent prostate cancer. A systematic review. Acta Biomed. 2021;92(4):e2021191. https:\/\/doi.org\/10.23750\/abm.v92i3.11475. (PMID: 34487074; PMCID: PMC8477121).","journal-title":"Acta Biomed"},{"issue":"2","key":"3315_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.euf.2015.04.006","volume":"1","author":"G Veereman","year":"2015","unstructured":"Veereman G, Jonckheer P, Desomer A, Van Brabandt H, D\u2019Hont C, Van Velthoven R, et al. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for localised prostate cancer. Eur Urol Focus. 2015;1(2):158\u201370. https:\/\/doi.org\/10.1016\/j.euf.2015.04.006. (Epub 2015 Jun 6 PMID: 28723429).","journal-title":"Eur Urol Focus"},{"key":"3315_CR20","doi-asserted-by":"publisher","unstructured":"H\u00e9tet JF, Colls P, Pocholle P, Chauveau P, Barr\u00e9 C, Hallouin P (2014) Cryoth\u00e9rapie de rattrapage apr\u00e8s radioth\u00e9rapie prostatique: principes, indications, s\u00e9lection des patients, r\u00e9sultats oncologiques et morbidit\u00e9 [Salvage cryotherapy for recurrent prostate cancer after radiotherapy failure: principles, indications, patient selection, oncological results and morbidity]. Cancer Radiother. 18(7): 701-8. French. doi: https:\/\/doi.org\/10.1016\/j.canrad.2014.04.002. Epub 2014 Jun 6. PMID: 24910288","DOI":"10.1016\/j.canrad.2014.04.002"},{"key":"3315_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22941","author":"PL Nguyen","year":"2007","unstructured":"Nguyen PL, D\u2019Amico AV, Lee AK, Suh WW. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer. 2007. https:\/\/doi.org\/10.1002\/cncr.22941.","journal-title":"Cancer"},{"issue":"Suppl 4","key":"3315_CR22","first-page":"S27","volume":"6","author":"JS Lam","year":"2004","unstructured":"Lam JS, Belldegrun AS. Salvage cryosurgery of the prostate after radiation failure. Rev Urol. 2004;6(Suppl 4):S27-36 (PMID: 16985867; PMCID: PMC1550974).","journal-title":"Rev Urol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03315-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-023-03315-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03315-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T08:06:12Z","timestamp":1711785972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-023-03315-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1007\/s12094-023-03315-1","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and agreed with the content of the submission, and they have no affiliations with or involvement in any organization or entity with any financial interest or nonfinancial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and written informed consent was obtained from all subjects. All data were de-identified, and no names or identifying information were revealed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was approved by our institutional review board and the requirement for informed patient consent was waived due to the retrospective nature of the study and written informed consent was obtained from all subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}